Clinical Trial

Nutritional Therapy for Delirium in Elderly Hospitalized Subjects

Recruiting
View on ClinicalTrials.gov →
Summary
The investigators have developed a proprietary blend of amino acids that they think will help to prevent or reduce the severity of delirium in older adults (60 years and older) who are hospitalized for certain infections. In this study, up to 60 people will be enrolled.20 will be asked to drink this blend twice a day for up to 4 days, and 20 will receive standard treatment in the hospital for the same time period. The other 20 subjects will be non-delirious control subjects who do not consume any study products.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2021-09-23; most recent amendment 2026-01-08.
Status change: Suspended → Recruiting 2025-03-10
Status change: Recruiting → Suspended 2024-12-20
Status change: Suspended → Recruiting 2023-09-18
Status change: Recruiting → Suspended 2023-09-05
Status change: Suspended → Recruiting 2022-11-01
Status change: Recruiting → Suspended 2022-08-09
Trial Details
NCT Number NCT05066503
Lead Sponsor University of Arkansas
Conditions Subacute Delirium
Enrollment 60 participants
Start Date 2020-11-16
Primary Completion 2026-08 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-12